PTX3 and obstructive sleep apnea syndrome: Kasai et al. demonstrated that not only did patients with OSA (n = 50) express higher levels of plasma PTX3 than individuals in an age- and body mass index-matched control group, but also that continuous positive airway pressure (CPAP) therapy led to a significant reduction in plasma PTX3 levels.